Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Dec;47(12):4148-4157.
doi: 10.1111/jog.15044. Epub 2021 Sep 27.

Gestational metformin administration in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized control studies

Qi Cao  1   2 , Yuanyuan Hu  1   2 , Jing Fu  1   2 , Xin Huang  1   2 , Lukanxuan Wu  1   2 , Jiani Zhang  1   2 , Wei Huang  1   2
Affiliations
Meta-Analysis

Gestational metformin administration in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized control studies

Qi Cao et al. J Obstet Gynaecol Res. 2021 Dec.

Abstract

Aims: To evaluate metformin's effects on pregnancy outcomes in women with polycystic ovary syndrome.

Methods: A literature search was conducted using PubMed, EMBASE, Web of Science, MEDLINE, and the Cochrane Library. All randomized controlled trials comparing metformin administration during pregnancy versus placebo or blank in PCOS women were selected. The primary outcomes were the incidence of gestational diabetes mellitus (GDM), preterm delivery, and miscarriage. We combined data with the Review Manager. Bayesian meta-analysis was employed for further verification with the R software.

Results: Six randomized control trial studies involving 1229 participants were included. Metformin use was associated with reduced risk of preterm delivery (Risk ratios [RR], 0.45; 95% CI, 0.25-0.80; p, 0.007) and higher larger neonatal head circumference (Mean difference (MD), 0.47; 95% CI, 0.20-0.74; p, 0.0006] but had no effect on the incidence of GDM (RR 1.87; 95% CI, 0.58-1.87; p, 0.89), miscarriage (RR, 0.85; 95% CI, 0.45-1.60; p, 0.62), pre-eclampsia (RR, 1.18; 95% CI, 0.43-3.21; p, 0.75), neonatal length (MD, 0.33; 95% CI, -0.12-0.78; p, 0.15) and birthweight (MD, 73.78; 95% CI, -52.98-200.53; p, 0.17).

Conclusions: Metformin administration in PCOS pregnancies was associated with reduced preterm delivery risk and larger neonatal head circumference.

Keywords: meta-analysis; metformin; polycystic ovary syndrome; pregnancy complications; preterm delivery.

PubMed Disclaimer

References

    1. Azziz R, Carmina E, Chen Z, Dunaif A, Laven JSE, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.
    1. Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reproduc (Oxford, England). 2018;33(9):1602-18.
    1. Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. BMJ (Clinical Research). 2011;343(1):d6309.
    1. Mills G, Badeghiesh A, Suarthana E, Baghlaf H, Dahan M. Associations between polycystic ovary syndrome and adverse obstetric and neonatal outcomes: a population study of 9.1 million births. Human Reproduc (Oxford, England). 2020;35(8):1914-21.
    1. Visser J. The importance of metabolic dysfunction in polycystic ovary syndrome. Nat Rev Endocrinol. 2020;17(2):77-8.

LinkOut - more resources